Long-Term Partnership Helps Advance Real World Evidence in Regulatory and Clinical Decision-Making

A leading pharmaceutical company faced significant challenges in demonstrating the real-world value of its novel cardiovascular therapy. Despite its efficacy, the treatment was underutilized, and access barriers prevented it from reaching high-risk patient populations. Additionally, the company needed robust real-world evidence (RWE) to support regulatory submissions and payer negotiations.

Axtria partnered with the client through a long-term Center of Excellence model, deploying a dedicated team of RWE experts, data scientists, and medical writers. Using advanced real-world data analytics and economic modeling, Axtria developed innovative simulations to assess treatment impact, generated insights to refine market access strategies, and supported scientific publications to strengthen regulatory engagement.

This collaboration led to significant outcomes, including updates to clinical practice guidelines, successful label expansions, and enhanced payer communication strategies. The effort resulted in more than 20 studies that contributed to numerous medical conference materials and peer-reviewed publications, elevating the company’s scientific reputation and market position.

Download the case study to explore how Axtria’s expertise in real-world evidence helped drive regulatory and clinical advancements.

Contact us at connect@axtria.com with any questions.